MAPT and Alzheimer disease: The microtubule-binding protein Tau, a cytoskeletal protein produced by alternative splicing of the MAPT gene, has been identified as a key molecule in AD, but also in a series of neurodegenerative diseases referred to as tauopathies, in contrast to Aβ accumulation, which is a characteristic exclusive to AD [15,33,34].